VR-Based Optokinetic Stimulation in Multiple Sclerosis

N/ANot Yet RecruitingNCT07150520

Avrasya University30 enrolled

Overview

The aim of this study is to investigate the acute effects of virtual reality-based optokinetic stimulation on postural sway and motion sickness symptoms in individuals with multiple sclerosis (MS)

This study will be conducted at Hacettepe University, Faculty of Physical Therapy and Rehabilitation. It will investigate the acute effects of virtual reality-based optokinetic stimulation (OKS) on postural sway and motion sickness symptoms in individuals with multiple sclerosis (MS). Participants will include MS patients with and without central vestibular dysfunction, as well as age- and sex-matched healthy controls. MS participants will first undergo vestibular function assessment using videonystagmography (VNG). Postural control will then be measured via a force platform under four conditions (bipodal/monopodal, eyes open/closed) before and after a 10-minute OKS session using Oculus Quest 2. Healthy participants will follow the same postural and OKS assessment protocol without VNG.Motion sickness and virtual reality effects will be evaluated using the Simulator Sickness Questionnaire. Data will be analyzed using appropriate parametric or non-parametric tests to compare postural sway and VR-related symptoms across groups, with significance set at p \< 0.05.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Multiple Sclerosis

Interventions

Virtual Reality-Based Optokinetic Stimulation (OKS)DEVICE

A 10-minute session of virtual reality-based optokinetic stimulation (OKS) using the Oculus Quest 2 system. The stimulation speed is set at 40°/s and the direction is determined according to Fukuda test results. Postural sway and motion sickness will be assessed before and after the intervention.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Be an adult aged 18-55 years * Have a confirmed diagnosis of MS by a neurologist (for MS groups) * Not have had a relapse in the last 3 months (for MS patients) * Have an Expanded Disability Status Scale (EDSS) score of ≤ 4 (for MS patients) * Be a healthy control with no condition preventing participation Exclusion Criteria: * Have peripheral vestibular dysfunction (for MS groups) * Be older than 55 years * Have any cardiovascular, orthopedic, neurological, or other condition preventing assessments * Have a history of neurological disorders, head trauma, or chronic psychiatric conditions (for healthy controls)

Outcomes

Primary Outcomes

Postural Sway

Postural sway will be assessed using the FreeMED force platform under four conditions (bipodal/monopodal, eyes open/closed) before and after a 10-minute virtual reality-based optokinetic stimulation (OKS) session. Parameters include sway path, mediolateral (delta X), and anteroposterior (delta Y) displacement.

Time frame: Immediately before and immediately after the 10-minute virtual reality-based optokinetic stimulation session

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.